MBX Biosciences (MBX) Non-cash Items (2023 - 2026)

MBX Biosciences has disclosed Non-cash Items across 4 years of filings, most recently posting $2.3 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $2.3 million, down 4.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 4.44% YoY), and the FY2025 annual result was $97.8 million, up 184.93% from the prior year.
• Non-cash Items came in at $2.3 million for Q1 2026 at MBX Biosciences, down from $97.8 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $97.8 million in Q4 2025 to a low of $2.3 million in Q1 2026.
• The 4-year median for Non-cash Items is $8.7 million (2023), against an average of $27.5 million.
• Across the five-year window, Non-cash Items soared 655.16% in 2024 and slumped 96.12% in 2025, its largest moves.
• MBX Biosciences' Non-cash Items stood at $4.5 million in 2023, then jumped by 655.16% to $34.3 million in 2024, then jumped by 184.93% to $97.8 million in 2025, then tumbled by 97.67% to $2.3 million in 2026.
• The last three Non-cash Items figures came in at $2.3 million (Q1 2026), $97.8 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.